Retatrutide's dysesthesia signal at high doses is a per-compound safety question
So, instead of just managing the symptom of T2Derratic blood sugarswith injected insulin, these new drugs help to address the root causeenergy toxicity
If youre not completely satisfied, let us know and well make it right
Though the drug is not available for purchase or prescription yet, medical professionals expect retatrutide to reshape obesity treatment once regulatory approval is complete
Phase 2 Data: The Evidence That Set Expectations The Phase 2 trial of retatrutide in adults with obesity, published in The New England Journal of Medicine in 2023, enrolled 338 participants across multiple dose cohorts and a placebo arm over 48 weeks [1]
Constipation, dizziness, and dark-colored urine may be signs that your body needs more fluids